【24h】

Methods for preliminary determination of pemetrexed in macromolecular drug-carrier systems

机译:高分子药物载体系统中培美曲塞的初步测定方法

获取原文
获取原文并翻译 | 示例
           

摘要

Pemetrexed (PMX) is an antifolate drug utilized in the treatment of non-small cell lung cancer. For studies of potential macromolecular carriers for PMX, fast and precise methods were developed to determine the bound and free drug contained in investigated conjugate preparations. The analysis of the total amount of PMX in conjugates was based on absorption spectrophotometry. The linearity was found in the range of 4.697-46.97 mu mol L-1 PMX. The limit of quantitation was 1.070 mu mol L-1. The method for the analysis of unbound PMX was based on size-exclusion chromatography and detection at 225 nm. This method shows linear range of 2.230-223.0 mu mol L-1. LOQ was 0.539 mu mol L-1. The proposed methods can be used both for the characterization of the polysaccharide based conjugates of PMX and for the determination of conjugate drug release profiles.
机译:培美曲塞(PMX)是一种抗叶酸药物,用于治疗非小细胞肺癌。为了研究潜在的PMX大分子载体,开发了快速,精确的方法来确定研究的结合物制剂中所含的结合药物和游离药物。结合物中PMX总量的分析基于吸收分光光度法。发现线性在4.697-46.97μmolL-1 PMX的范围内。定量限为1.070μmolL-1。未结合的PMX的分析方法基于尺寸排阻色谱法,并在225 nm处检测。该方法的线性范围为2.230-223.0μmol L-1。 LOQ为0.539μmolL-1。所提出的方法既可用于表征基于多糖的PMX缀合物,又可用于确定缀合物的药物释放曲线。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号